Stock Rich List
Nasdaq: RNA

Atrium Therapeutics insiders

The officers, directors and 10% owners of Atrium Therapeutics, Inc. who hold the most stock, valued at the live RNA price.

$6.98
RNA today +$340K (+5.12%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
1
Their RNA stock
$82K

Insiders by value of RNA holdings

SEC ownership page
#InsiderRoleSharesValueOverall rank
1Troy E. WilsonDirector11,731$82K8690th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Atrium Therapeutics; see each profile for the filing.